Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Food and Drug Administration Orphan Products Development
Grant: R01 FD-R-002568
U.S. Food and Drug Administration Orphan Products Development
Grant: R01 FD-R-003409
National Institute of Child Health and Human Development
Grant: R21 HD078864
National Center for Research Resources
Grant: M01 RR00052
National Institute of Dental and Craniofacial Research
Grant: 640T90DE021989-09
NCRR NIH HHS
Grant: M01 RR000052
National Institutes of Health
Grant: 3R01FD002568-03S2
Growth Hormone Use in Pseudohypoparathyroidism Type 1A
National Institutes of Health
Grant: 3M01RR000052-31S3
GCRC-RENOVATION
National Institutes of Health
Grant: 5R01FD003409-03
Phase 2 of Growth Hormone for Treatment of Albright Hereditary Osteodystrophy
National Institutes of Health
Grant: 7R21HD078864-02
The role of G protein-coupled signaling in neurocognitive and psychosocialabnormalities
FWCI
1.08
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals